Article
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma
17 Oct 2023
Abstract excerpt
BACKGROUND: Glioblastoma (GBM) has poor prognosis due to ineffective agents and poor delivery methods. MicroRNAs (miRs) have been explored as novel therapeutics for GBM, but the optimal miRs and the ideal delivery strategy remain unresolved. In this study, we sought to identify the most effective pan-subtype anti-GBM miRs and to develop an improved delivery system for these miRs. METHODS: We conducted an unbiased...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
